The global Veterinary Therapeutics Market was valued at USD 43.58 billion in 2023 and is projected to grow to USD 82.40 billion by 2032, expanding at a robust compound annual growth rate (CAGR) of 7.35% during the forecast period from 2024 to 2032. This growth is primarily driven by the increasing demand for animal healthcare, advancements in veterinary therapeutics, rising pet ownership, and growing awareness about animal diseases and treatments.
The veterinary therapeutics market includes a range of products aimed at preventing, managing, and treating diseases in animals, both companion animals (pets) and livestock. As the global population of pets continues to rise and the agricultural industry continues to evolve, the demand for innovative and effective veterinary treatments is expected to increase significantly, bolstering the market’s growth trajectory.
Get Free Sample Report on Veterinary Therapeutics Market
https://www.snsinsider.com/sample-request/1082
Key Drivers of Market Growth
Several factors are contributing to the growth of the veterinary therapeutics market. These include advancements in veterinary medicines, the rising global trend of pet adoption, the increasing focus on animal welfare, and the need for better disease management in livestock populations.
- Increase in Pet Ownership: The global trend of pet adoption is a significant factor driving the demand for veterinary therapeutics. According to the American Pet Products Association (APPA), over 70 million households in the U.S. alone have pets, and similar trends are being observed in countries across the globe. As more people treat pets as family members, the demand for veterinary care, including therapeutics for managing chronic diseases, preventive care, and emergency treatments, has skyrocketed.
- Technological Advancements: Ongoing innovations in veterinary therapeutics are enabling the development of new and more effective treatments. This includes advancements in biologics, such as vaccines, monoclonal antibodies, and gene therapies, as well as improvements in pharmaceutical formulations that allow for better absorption and targeted treatment. These innovations are enhancing the quality of life for animals, improving disease management, and offering more effective solutions for complex medical conditions.
- Growing Demand for Livestock Health Management: Livestock farming remains a major economic activity worldwide, particularly in emerging markets. The need for efficient disease control, growth enhancement, and productivity improvement in livestock has led to an increased demand for veterinary therapeutics. The rising awareness about food safety and the growing focus on improving the health of livestock are key factors driving the market for veterinary therapeutics in the agriculture sector.
- Rising Awareness of Animal Welfare: Growing awareness about the importance of animal health and welfare is contributing to the increased demand for veterinary therapeutics. Consumers, particularly in developed regions, are becoming more conscious about the quality of life of animals, which has prompted more stringent regulations on animal treatment and healthcare. This is influencing the adoption of better veterinary therapeutic practices for companion animals and livestock.
Key Market Segments
By Product type
- Vaccines Type
- Drugs Type
- Medicated Feed Additives
By Animal type
- Livestock Animals
- Companion Animal
By Route of administration
- Parenteral
- Oral
- Topical
By End-user
- Drug Stores
- Veterinary Clinics
- Veterinary Hospitals
- Pharmacies
List of Key Players and Their Products in the Veterinary Therapeutics Market
- Zoetis, Inc. - Apoquel (allergy treatment), Simparica Trio (flea, tick, and heartworm protection), Rimadyl (pain relief), Convenia (antibiotics), Vanguard vaccines.
- Intervet Inc. (Merck Animal Health) - Nobivac vaccines (for dogs and cats), Banamine (pain relief), Safe-Guard (antiparasitic), Zuprevo (respiratory disease treatment), Revalor (growth implants).
- Elanco Animal Health- Trifexis (flea, heartworm, intestinal parasite control), Galliprant (pain and inflammation relief), Cydectin (antiparasitic), Inteprity (poultry gut health management).
- Merial (Acquired by Boehringer Ingelheim) - Frontline (flea and tick prevention), Heartgard (heartworm disease prevention), Purevax vaccines (cats).
- Bayer AG (Now part of Elanco Animal Health) - Advantix (flea and tick treatment), Baytril (antibiotics), Profender (dewormer).
- Boehringer Ingelheim InternationalGmbH - NexGard (flea and tick control), Ingelvac (swine vaccines), Duramune (canine vaccines), Metacam (pain relief).
- Ceva Santé Animale - Vectra (flea and tick treatment), Cevac vaccines (for poultry), Adaptil (stress management in dogs), Feliway (cat pheromone product).
- Vetoquinol S.A. - Marbocyl (antibiotics), Clavaseptin (antimicrobial), Vetprofen (pain management), Zylkene (behavior support).
- IDEXX Laboratories, Inc. - SNAP diagnostics (rapid tests for diseases like parvovirus and heartworm), Cornerstone software (veterinary practice management).
Make Enquiry about Veterinary Therapeutics Market
https://www.snsinsider.com/enquiry/1082
Conclusion
The veterinary therapeutics market is poised for significant growth in the coming years, driven by increasing pet ownership, advancements in veterinary care, rising awareness of animal health, and growing demand for effective livestock management solutions. With a projected market value of USD 82.40 billion by 2032, the veterinary therapeutics industry is on a strong growth trajectory, offering ample opportunities for innovation and investment. As the focus on animal health continues to rise globally, the market is expected to evolve with new, cutting-edge treatments, enhancing the quality of life for animals while meeting the needs of veterinarians and animal owners alike.
About US:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)